Heart remodeling in elderly patients with isolated systolic arterial hypertension and chronic heart failure with preserved left ventricular ejection fraction
DOI:
https://doi.org/10.14739/2310-1210.2021.3.224668Keywords:
isolated systolic arterial hypertension, chronic heart failure, cardiac outputAbstract
The aim of the work was to study the structural and functional state of the left ventricle (LV) in elderly patients with isolated systolic arterial hypertension (ISAH) and chronic heart failure with preserved ejection fraction (CHF with PEF).
Materials and methods. After receiving an informed consent, 134 elderly patients with ISAH were enrolled in the study. The main group included 91 patients aged 71.1 ± 3.5 years with ISAH and ejection fraction (EF) of the LV >50 % and a level of natriuretic peptide (NT-proBNP) >125 pg/ml. Among them, there were 61 women (67 %) and 30 (33 %) men. The comparison group consisted of 43 patients (27 women and 16 men aged 70.4 ± 3.7 years) with ISAH, LV EF >50% and NT-proBNP <125 pg/ml. The geometric changes of the LV were evaluated taking into account the LV myocardial mass index and the relative LV wall thickness.
Results. Cardiac remodeling in elderly ISAH patients with CHF and PEF was represented by the following geometric variants of the LV. In the main group patients, concentric LV hypertrophy (LVH) prevailed – 73 (80.2 %) patients, while in the comparison group, concentric modeling (CR) – 25 (58.1 %) patients (P < 0.01 by criterion χ2). CR in the ISAH patients with CHF and PEF was diagnosed in 18 (19.8 %) cases. Concentric LVH was verified in 18 (41.9 %) patients of the comparison group (P < 0.01). It was determined that the hyperfunction of the left atrium (LA) in the patients with ISAH without CHF was compensatory. The maximum volume index of the LA (VILAmax.) in these patients was in the range of 27–32 ml/m2. Hyperfunction of the LA in the ISAH patients with CHF and PEF was accompanied by a statistically significant increase in VILAmax. over 34 ml/m2.
Conclusions. The prevalence of ISAH among elderly patients is 35.6 %. The formation of a hypertensive heart in the ISAH patients with CHF and PEF is characterized by a predominant concentric LVH (80.2 %) and hyperfunction of the LA. A significant increase in the LA volumes testifies to increase in its contribution to the LV filling with the formation of LV diastolic dysfunction. The presence of concentric LVH and an increase in VILAmax. ≥34 ml/m2 is a criterion for identifying individuals at high and very high risk among elderly ISAH patients with CHF and PEF.
References
Zhdan, V. М., Kitura, О. Ye., Kitura, Ye. М., Babanina, М. Yu., & Tkachenko, М. V. (2020). Arterial Hypertension and Heart Failure in General Practice. Semeinaya meditsina, (1-2), 85-86. https://doi.org/10.30841/2307-5112.1-2.2020.204541
Diachuk, D., Moroz, H., Hidzynska, I., Kravchenko, A., Lasytsya, T., & Dzizinska, O. (2019). Profilaktyka sertsevo-sudynnykh zakhvoryuvan: teoretychni zasady ta praktychne vprovadzhennia [Prevention of cardiovascular diseases: theoretical principles and practical implementation]. DNU «NPTs PKM» DUS. https://doi.org/10.31612/9786176968719 [in Ukrainian].
Jayarajah, U., & Seneviratne, S. L. (2019). Environmental Aspects of Hypertension. In H. Uzun & P. Atukeren (Eds.), Current and Future Developments in Hypertension. Volume 1. Novel Strategies and Approaches in Hypertension Therapy (pp. 1-56). Bentham E Books. https://doi.org/10.2174/9789811422720119010004
Kovalenko, V. M., Lutai, M. I., Sirenko, Yu. M., & Sychov, O. S. (Eds.). (2016). Sertsevo-sudynni zakhvoriuvannia. Klasyfikatsiia, standarty diahnostyky ta likuvannia [Cardiovascular diseases. Classification, standards of diagnosis and treatment]. MORION. [in Ukrainian].
Voronkov, L., Filatova, E., Lyashenko, A., Tkach, N., & Babych, P. (2017). 36 months survivability and its predictors in patients with chronic heart failure and decreased fraction of left ventricular ejection depending on sex. EUREKA: Health Sciences, (5), 44-49. https://doi.org/10.21303/2504-5679.2017.00408
González, A., Ravassa, S., López, B., Moreno, M. U., Beaumont, J., San José, G., Querejeta, R., Bayés-Genís, A., & Díez, J. (2018). Myocardial Remodeling in Hypertension. Hypertension, 72(3), 549-558. https://doi.org/10.1161/HYPERTENSIONAHA.118.11125
Matova, О. О., Mishchenko, L. A., Kupchynska, O. H., & Serbeniuk, K. I. (2020). Tryrichna dynamika strukturnykh pokaznykiv livoho shlunochka u khvorykh na rezystentnu arterialnu hipertenziiu na tli chotyrykomponentnoi terapii [Three-year dynamics of left ventricular structural parameters in patients with resistant arterial hypertension on four-component therapy]. Zaporozhye medical journal, (6), 740-748. https://doi.org/10.14739/2310-1210.2020.6.218296
Marwick, T. H., Gillebert, T. C., Aurigemma, G., Chirinos, J., Derumeaux, G., Galderisi, M., Gottdiener, J., Haluska, B., Ofili, E., Segers, P., Senior, R., Tapp, R. J., & Zamorano, J. L. (2017). Rekomendatsii po primeneniyu ekhokardiografii pri arterial'noi gipertenzii u vzroslykh: otchet Evropeiskoi assotsiatsii po serdechno-sosudistoi vizualizatsii (EACVI) i Amerikanskogo ekhokardiograficheskogo obshchestva (ASE) [Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)]. Sistemnaya gipertenziya, 14(2), 6-28. https://doi.org/10.26442/2075-082x_14.2.6-28 [in Russian].
Ashcheulova, T., Honchar, O., Smyrnova, V., Gerasimchuk, N., & Ivanchenko, S. (2017). Left ventricular remodeling in hypertension: evolution of the approach (review). Inter Collegas, 4(4), 167-172. https://doi.org/10.35339/ic.4.4.167-172
Lønnebakken, M. T., Izzo, R., Mancusi, C., Gerdts, E., Losi, M. A., Canciello, G., Giugliano, G., De Luca, N., Trimarco, B., & de Simone, G. (2017). Left Ventricular Hypertrophy Regression During Antihypertensive Treatment in an Outpatient Clinic (the Campania Salute Network). Journal of the American Heart Association, 6(3), Article e004152. https://doi.org/10.1161/JAHA.116.004152
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., Kahan, T., Mahfoud, F., Redon, J., Ruilope, L., Zanchetti, A., Kerins, M., Kjeldsen, S. E., Kreutz, R., Laurent, S., Lip, G., … Authors/Task Force Members. (2018). 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Journal of Hypertension, 36(10), 1953-2041. https://doi.org/10.1097/HJH.0000000000001940
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G., Coats, A. J., Falk, V., González-Juanatey, J. R., Harjola, V. P., Jankowska, E. A., Jessup, M., Linde, C., Nihoyannopoulos, P., Parissis, J. T., Pieske, B., Riley, J. P., Rosano, G. M., Ruilope, L. M., Ruschitzka, F., Rutten, F. H., … van der Meer, P. (2016). Wytyczne ESC dotyczące diagnostyki i leczenia ostrej i przewlekłej niewydolności serca w 2016 roku. Kardiologia Polska, 74(10), 1037-1147. https://doi.org/10.5603/KP.2016.0141
Perrone-Filardi, P., Coca, A., Galderisi, M., Paolillo, S., Alpendurada, F., de Simone, G., Donal, E., Kahan, T., Mancia, G., Redon, J., Schmieder, R., Williams, B., & Agabiti-Rosei, E. (2017). Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: A consensus paper from the European Association of Cardiovascular Imaging (EACVI), the European Society of Cardiology Council on Hypertension, and the European Society of Hypertension (ESH). European Heart Journal - Cardiovascular Imaging, 18(9), 945-960. https://doi.org/10.1093/ehjci/jex094
Cuspidi, C., Facchetti, R., Bombelli, M., Tadic, M., Sala, C., Grassi, G., & Mancia, G. (2019). High Normal Blood Pressure and Left Ventricular Hypertrophy Echocardiographic Findings From the PAMELA Population. Hypertension, 73(3), 612-619. https://doi.org/10.1161/HYPERTENSIONAHA.118.12114
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., Delling, F. N., Djousse, L., Elkind, M., Ferguson, J. F., Fornage, M., Jordan, L. C., Khan, S. S., Kissela, B. M., Knutson, K. L., Kwan, T. W., … American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. (2019). Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation, 139(10), e56-e528. https://doi.org/10.1161/CIR.0000000000000659
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
